Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Investigating the Role of Minimally Invasive Radical Hysterectomy in Cervical Cancer.

Bogani G, Ditto A, Martinelli F, Chiappa V, Leone Roberti Maggiore U, Lorusso D, Raspagliesi F.

J Invest Surg. 2018 Nov 2:1-2. doi: 10.1080/08941939.2018.1505010. [Epub ahead of print] No abstract available.

PMID:
30388913
2.

Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study.

Raspagliesi F, Bogani G, Matteucci L, Casarin J, Sabatucci I, Tamberi S, Arcangeli V, Maltese G, Lepori S, Comerci G, Stefanetti M, Ditto A, Martinelli F, Chiappa V, Lorusso D.

Int J Gynecol Cancer. 2018 Nov;28(9):1706-1713. doi: 10.1097/IGC.0000000000001286.

PMID:
30376554
3.

New prophylactics human papilloma virus (HPV) vaccines against cervical cancer.

Barra F, Leone Roberti Maggiore U, Bogani G, Ditto A, Signorelli M, Martinelli F, Chiappa V, Lorusso D, Raspagliesi F, Ferrero S.

J Obstet Gynaecol. 2018 Oct 27:1-10. doi: 10.1080/01443615.2018.1493441. [Epub ahead of print]

PMID:
30370796
4.

Current landscape and future perspective of sentinel node mapping in endometrial cancer.

Bogani G, Raspagliesi F, Leone Roberti Maggiore U, Mariani A.

J Gynecol Oncol. 2018 Nov;29(6):e94. doi: 10.3802/jgo.2018.29.e94. Review.

5.

The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer.

Bogani G, Leone Roberti Maggiore U, Chiappa V, Ditto A, Martinelli F, Sabatucci I, Mosca L, Lorusso D, Raspagliesi F.

Int J Gynaecol Obstet. 2018 Dec;143(3):319-324. doi: 10.1002/ijgo.12667. Epub 2018 Oct 15.

PMID:
30194778
6.

Early diagnosis in endometrial cancer minimizes the impact of treatments.

Bogani G, Ditto A, Raspagliesi F.

Am J Obstet Gynecol. 2018 Aug 23. pii: S0002-9378(18)30676-8. doi: 10.1016/j.ajog.2018.08.023. [Epub ahead of print] No abstract available.

PMID:
30144399
7.

Rectus Abdominis Myofascial Flap for Vaginal Reconstruction After Pelvic Exenteration.

Cortinovis U, Sala L, Bonomi S, Gallino G, Belli F, Ditto A, Martinelli F, Bogani G, Leone Roberti Maggiore U, Raspagliesi F.

Ann Plast Surg. 2018 Nov;81(5):576-583. doi: 10.1097/SAP.0000000000001578.

PMID:
30113980
8.

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.

Gadducci A, Grosso F, Scambia G, Raspagliesi F, Colombo N, Grignani G, Casali P, Sanfilippo R, Buonadonna A, Santoro A, Bruzzone M, Artioli G, Lorusso D, Biagioli E, Fossati R, Galli F, Negri E, Rulli E, Torri V, D'Incalci M.

Br J Cancer. 2018 Aug;119(5):565-571. doi: 10.1038/s41416-018-0190-y. Epub 2018 Jul 30.

PMID:
30057406
9.

Lynch syndrome - Muir-Torre variant: implication in gynecologic oncology.

Bogani G, Leone Roberti Maggiore U, Raspagliesi F.

J Gynecol Oncol. 2018 Sep;29(5):e84. doi: 10.3802/jgo.2018.29.e84. No abstract available.

10.

Correction to: Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jul 25:391. doi: 10.1007/s00428-018-2419-9. [Epub ahead of print]

PMID:
30043108
11.

Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer.

Bogani G, Rossetti D, Ditto A, Martinelli F, Chiappa V, Mosca L, Leone Roberti Maggiore U, Ferla S, Lorusso D, Raspagliesi F.

J Gynecol Oncol. 2018 Sep;29(5):e66. doi: 10.3802/jgo.2018.29.e66. Epub 2018 Apr 23.

12.

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth.

Rea K, Roggiani F, De Cecco L, Raspagliesi F, Carcangiu ML, Nair-Menon J, Bagnoli M, Bortolomai I, Mezzanzanica D, Canevari S, Kourtidis A, Anastasiadis PZ, Tomassetti A.

J Exp Clin Cancer Res. 2018 Jul 11;37(1):146. doi: 10.1186/s13046-018-0796-1.

13.

Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer.

Bogani G, Ditto A, Leone Roberti Maggiore U, Scaffa C, Mosca L, Chiappa V, Martinelli F, Lorusso D, Raspagliesi F.

Tumori. 2018 Jul 1:300891618784785. doi: 10.1177/0300891618784785. [Epub ahead of print]

PMID:
29984612
14.

The impact of morcellation on survival outcomes of undiagnosed uterine sarcoma.

Raspagliesi F, Bogani G, Lorusso D.

Gynecol Oncol Rep. 2018 Jan 28;23:37-38. doi: 10.1016/j.gore.2018.01.007. eCollection 2018 Feb. No abstract available.

15.

Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy.

Lorusso D, Tripodi E, Maltese G, Lepori S, Sabatucci I, Bogani G, Raspagliesi F.

Drug Des Devel Ther. 2018 May 29;12:1501-1509. doi: 10.2147/DDDT.S124447. eCollection 2018. Review.

16.

Potential impact of introducing a nonavalent HPV vaccination.

Bogani G, Taverna F, Lombardo C, Signorelli M, Chiappa V, Casarin J, Scaffa C, Leone Roberti Maggiore U, Recalcati D, Ditto A, Martinelli F, Borghi C, Perotto S, Ferrero S, Lorusso D, Raspagliesi F.

Int J Gynaecol Obstet. 2018 Sep;142(3):338-342. doi: 10.1002/ijgo.12546. Epub 2018 Jun 28.

PMID:
29858884
17.

Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, Glenn McCluggage W, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jun;472(6):937-938. doi: 10.1007/s00428-018-2380-7. Erratum in: Virchows Arch. 2018 Jul 25;:391.

PMID:
29789924
18.

Role of bevacizumab in uterine leiomyosarcoma.

Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Fonatella C, Sanfilippo R, Leone Roberti Maggiore U, Ferrero S, Lorusso D, Raspagliesi F.

Crit Rev Oncol Hematol. 2018 Jun;126:45-51. doi: 10.1016/j.critrevonc.2018.03.019. Epub 2018 Mar 29. Review.

PMID:
29759566
19.

LASER treatment for women with high-grade vaginal intraepithelial neoplasia: A propensity-matched analysis on the efficacy of ablative versus excisional procedures.

Bogani G, Ditto A, Martinelli F, Mosca L, Chiappa V, Rossetti D, Leone Roberti Maggiore U, Sabatucci I, Lorusso D, Raspagliesi F.

Lasers Surg Med. 2018 Sep;50(9):933-939. doi: 10.1002/lsm.22941. Epub 2018 May 14.

PMID:
29756652
20.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Radiother Oncol. 2018 Jun;127(3):404-416. doi: 10.1016/j.radonc.2018.03.003. Epub 2018 May 1.

PMID:
29728273
21.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jun;472(6):919-936. doi: 10.1007/s00428-018-2362-9. Epub 2018 May 4. Erratum in: Virchows Arch. 2018 May 23;:.

PMID:
29725757
22.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Int J Gynecol Cancer. 2018 May;28(4):641-655. doi: 10.1097/IGC.0000000000001216.

PMID:
29688967
23.

Factors Predictive of 90-Day Morbidity, Readmission, and Costs in Patients Undergoing Pelvic Exenteration.

Bogani G, Signorelli M, Ditto A, Martinelli F, Casarin J, Mosca L, Leone Roberti Maggiore U, Chiappa V, Lorusso D, Raspagliesi F.

Int J Gynecol Cancer. 2018 Jun;28(5):975-982. doi: 10.1097/IGC.0000000000001251.

PMID:
29683876
24.

Findings Linking Mismatch Repair Mutation With Age at Endometrial and Ovarian Cancer Onset in Lynch Syndrome.

Bogani G, Leone Roberti Maggiore U, Lorusso D, Raspagliesi F.

JAMA Oncol. 2018 Jun 1;4(6):889. doi: 10.1001/jamaoncol.2018.0253. No abstract available.

PMID:
29621388
25.

Ovarian preservation in locally advanced cervical cancer undergoing neoadjuvant chemotherapy and radical surgery.

Signorelli M, Bogani G, Chiappa V, Ditto A, Scaffa C, Martinelli F, Lorusso D, Raspagliesi F.

Minerva Ginecol. 2018 Aug;70(4):357-363. doi: 10.23736/S0026-4784.18.04221-1. Epub 2018 Mar 30.

PMID:
29600835
26.

Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study.

Bergamini A, Ferrandina G, Candiani M, Cormio G, Giorda G, Lauria R, Perrone AM, Scarfone G, Breda E, Savarese A, Frigerio L, Gadducci A, Mascilini F, Maneschi F, Cassani C, Marchetti C, Cecere SC, Biglia N, De Giorgi U, Raspagliesi F, Lorusso D, Mangili G.

Eur J Surg Oncol. 2018 Jun;44(6):766-770. doi: 10.1016/j.ejso.2018.03.001. Epub 2018 Mar 10.

PMID:
29576462
27.

Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer.

Ditto A, Bogani G, Leone Roberti Maggiore U, Martinelli F, Chiappa V, Lopez C, Perotto S, Lorusso D, Raspagliesi F.

J Gynecol Oncol. 2018 May;29(3):e41. doi: 10.3802/jgo.2018.29.e41. Epub 2018 Feb 28.

28.

A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses.

Bogani G, Tagliabue E, Signorelli M, Ditto A, Martinelli F, Chiappa V, Mosca L, Sabatucci I, Leone Roberti Maggiore U, Lorusso D, Raspagliesi F.

J Gynecol Oncol. 2018 May;29(3):e40. doi: 10.3802/jgo.2018.29.e40. Epub 2018 Feb 23.

29.

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer.

Piccirillo MC, Scambia G, Bologna A, Signoriello S, Vergote I, Baumann K, Lorusso D, Murgia V, Sorio R, Ferrandina G, Sacco C, Cormio G, Breda E, Cinieri S, Natale D, Mangili G, Pisano C, Cecere SC, Di Napoli M, Salutari V, Raspagliesi F, Arenare L, Bergamini A, Bryce J, Daniele G, Gallo C, Pignata S, Perrone F.

Ann Oncol. 2018 May 1;29(5):1189-1194. doi: 10.1093/annonc/mdy062.

PMID:
29462248
30.

The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment.

Bogani G, Leone Roberti Maggiore U, Signorelli M, Martinelli F, Ditto A, Sabatucci I, Mosca L, Lorusso D, Raspagliesi F.

Crit Rev Oncol Hematol. 2018 Feb;122:92-97. doi: 10.1016/j.critrevonc.2017.12.017. Epub 2017 Dec 28. Review.

PMID:
29458794
31.

Predicting Factors for High-Grade Cervical Dysplasia in Women With Low-Grade Cervical Cytology and Nonvisible Squamocolumnar Junction.

Bogani G, Taverna F, Lombardo C, Ditto A, Martinelli F, Signorelli M, Chiappa V, Leone Roberti Maggiore U, Mosca L, Sabatucci I, Scaffa C, Lorusso D, Raspagliesi F.

Reprod Sci. 2018 Jan 1:1933719118756747. doi: 10.1177/1933719118756747. [Epub ahead of print]

PMID:
29402202
32.

Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach.

Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Leone Roberti Maggiore U, Taverna F, Lombardo C, Borghi C, Scaffa C, Lorusso D, Raspagliesi F.

Eur J Cancer Prev. 2018 Jan 22. doi: 10.1097/CEJ.0000000000000432. [Epub ahead of print]

PMID:
29360648
33.

Minimally Invasive Nerve-Sparing Radical Hysterectomy: A Win-Win Scenario.

Bogani G, Raspagliesi F.

J Invest Surg. 2018 Jan 16:1-2. doi: 10.1080/08941939.2017.1413149. [Epub ahead of print] No abstract available.

PMID:
29336619
34.

Nerve-Sparing Approach Improves Outcomes of Patients Undergoing Minimally Invasive Radical Hysterectomy: A Systematic Review and Meta-Analysis.

Bogani G, Rossetti DO, Ditto A, Signorelli M, Martinelli F, Mosca L, Scaffa C, Leone Roberti Maggiore U, Chiappa V, Sabatucci I, Lorusso D, Raspagliesi F.

J Minim Invasive Gynecol. 2018 Mar - Apr;25(3):402-410. doi: 10.1016/j.jmig.2017.11.014. Epub 2017 Dec 2. Review.

PMID:
29191471
35.

The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study.

Bogani G, Matteucci L, Tamberi S, Arcangeli V, Ditto A, Maltese G, Signorelli M, Martinelli F, Chiappa V, Leone Roberti Maggiore U, Perotto S, Scaffa C, Comerci G, Stefanetti M, Raspagliesi F, Lorusso D.

Int J Gynecol Cancer. 2017 Nov;27(9):1856-1862. doi: 10.1097/IGC.0000000000001108.

PMID:
29064913
36.

Invasive Paget Disease of the Vulva.

Borghi C, Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Scaffa C, Perotto S, Leone Roberti Maggiore U, Recalcati D, Lorusso D, Raspagliesi F.

Int J Gynecol Cancer. 2018 Jan;28(1):176-182. doi: 10.1097/IGC.0000000000001131.

PMID:
28976448
37.

Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: A multi-institutional experience.

Raspagliesi F, Bogani G, Spinillo A, Ditto A, Bogliolo S, Casarin J, Leone Roberti Maggiore U, Martinelli F, Signorelli M, Gardella B, Chiappa V, Scaffa C, Ferrero S, Cromi A, Lorusso D, Ghezzi F.

Eur J Surg Oncol. 2017 Nov;43(11):2150-2156. doi: 10.1016/j.ejso.2017.08.015. Epub 2017 Sep 7.

PMID:
28927778
38.

Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features.

Maltese G, Fontanella C, Lepori S, Scaffa C, Fucà G, Bogani G, Provenzano S, Carcangiu ML, Raspagliesi F, Lorusso D.

Oncology. 2018;94(1):1-6. doi: 10.1159/000479818. Epub 2017 Sep 5.

PMID:
28869928
39.

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.

Pignata S, Scambia G, Bologna A, Signoriello S, Vergote IB, Wagner U, Lorusso D, Murgia V, Sorio R, Ferrandina G, Sacco C, Cormio G, Breda E, Cinieri S, Natale D, Mangili G, Pisano C, Cecere SC, Di Napoli M, Salutari V, Raspagliesi F, Arenare L, Bergamini A, Bryce J, Daniele G, Piccirillo MC, Gallo C, Perrone F.

J Clin Oncol. 2017 Oct 10;35(29):3347-3353. doi: 10.1200/JCO.2017.73.4293. Epub 2017 Aug 21.

PMID:
28825853
40.

Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers.

Raspagliesi F, Bogani G, Ditto A, Martinelli F, Chiappa V, Borghi C, Scaffa C, Morano F, Maltese G, Lorusso D.

Ann Surg Oncol. 2017 Oct;24(11):3396-3405. doi: 10.1245/s10434-017-6030-0. Epub 2017 Aug 9.

PMID:
28795373
41.

Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein.

Erba E, Romano M, Gobbi M, Zucchetti M, Ferrari M, Matteo C, Panini N, Colmegna B, Caratti G, Porcu L, Fruscio R, Perlangeli MV, Mezzanzanica D, Lorusso D, Raspagliesi F, D'Incalci M.

Biochem Pharmacol. 2017 Nov 15;144:52-62. doi: 10.1016/j.bcp.2017.08.001. Epub 2017 Aug 4.

PMID:
28782526
42.

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.

Bogani G, Tagliabue E, Ditto A, Signorelli M, Martinelli F, Casarin J, Chiappa V, Dondi G, Leone Roberti Maggiore U, Scaffa C, Borghi C, Montanelli L, Lorusso D, Raspagliesi F.

Gynecol Oncol. 2017 Oct;147(1):61-65. doi: 10.1016/j.ygyno.2017.07.139. Epub 2017 Aug 2.

PMID:
28779965
43.

Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy.

Martinelli F, Ditto A, Bogani G, Raspagliesi F.

Obstet Gynecol. 2017 Aug;130(2):469-470. doi: 10.1097/AOG.0000000000002183. No abstract available.

PMID:
28742659
44.

Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas.

Ferrero S, Leone Roberti Maggiore U, Aiello N, Barra F, Ditto A, Bogani G, Raspagliesi F, Lorusso D.

Expert Opin Drug Metab Toxicol. 2017 Aug;13(8):881-889. doi: 10.1080/17425255.2017.1351943. Epub 2017 Jul 13. Review.

PMID:
28678537
45.

Safety and effectiveness of Human Papillomavirus (HPV) vaccination: NCI of Milan position statement.

Bogani G, Lorusso D, Raspagliesi F.

Vaccine. 2017 Sep 18;35(39):5227. doi: 10.1016/j.vaccine.2017.06.068. Epub 2017 Jun 29. No abstract available.

PMID:
28669614
46.

Regarding "The Role of Routine Peritoneal and Omental Biopsies at Risk-reducing Salpingo-oophorectomy".

Bogani G, Signorelli M, Chiappa V, Carcangiu ML, Martinelli F, Paolini B, Leone Roberti Maggiore U, Gennaro M, Borghi C, Scaffa C, Ditto A, Lorusso D, Raspagliesi F.

J Minim Invasive Gynecol. 2017 Nov - Dec;24(7):1243-1244. doi: 10.1016/j.jmig.2017.05.020. Epub 2017 Jun 23. No abstract available.

PMID:
28648838
47.

Treatment of Genital Melanoma: Are We Ready for Innovative Therapies?

Ditto A, Bogani G, Martinelli F, Raspagliesi F.

Int J Gynecol Cancer. 2017 Jul;27(6):1063. doi: 10.1097/IGC.0000000000001018. No abstract available.

PMID:
28640175
48.

Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: A single center evaluation over 200 cases.

Martinelli F, Ditto A, Signorelli M, Bogani G, Chiappa V, Lorusso D, Scaffa C, Recalcati D, Perotto S, Haeusler E, Raspagliesi F.

Gynecol Oncol. 2017 Sep;146(3):525-530. doi: 10.1016/j.ygyno.2017.06.014. Epub 2017 Jul 5.

PMID:
28625394
49.

Sentinel-lymph-node mapping in endometrial cancer.

Bogani G, Ditto A, Leone Roberti Maggiore U, Lorusso D, Raspagliesi F.

Lancet Oncol. 2017 May;18(5):e234. doi: 10.1016/S1470-2045(17)30247-4. No abstract available.

PMID:
28495280
50.

Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.

Bogani G, Tagliabue E, Signorelli M, Chiappa V, Carcangiu ML, Paolini B, Casarin J, Scaffa C, Gennaro M, Martinelli F, Borghi C, Ditto A, Lorusso D, Raspagliesi F.

J Minim Invasive Gynecol. 2017 Jul - Aug;24(5):837-842. doi: 10.1016/j.jmig.2017.04.017. Epub 2017 May 4.

PMID:
28479170

Supplemental Content

Loading ...
Support Center